← 產業報告目錄
Biopharmaceutical Excipient Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Excipients), By Type of Biologics, By Scale Of Operation, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-20頁數 190報告編號 INSIGHTACE-a3caa9a76a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Biopharmaceutical Excipient Manufacturing Market is positioned for steady expansion, with a projected CAGR of 5.0% from 2025 to 2034.
The Biopharmaceutical Excipient Manufacturing sector involves key industry insights & findings from the report:
Increasing need for generic drugs and pharmaceutical products is driving the biopharmaceutical excipient manufacturing market. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharmaceutical Excipient Manufacturing Market Snapshot
Chapter 4. Global Biopharmaceutical Excipient Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Of Biologics, Estimates & Trend Analysis
5.1. By Type Of Biologics, & Market Share, 2024 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type Of Biologics:
5.2.1. Antibodies
5.2.2. Vaccines
5.2.3. Cell Therapies
5.2.4. Other Biologics
Chapter 6. Market Segmentation 2: By Product Type Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
6.2.1. Solubilizers & Surfactants/Emulsifiers
6.2.1.1. Triglycerides
6.2.1.2. Esters
6.2.1.3. Others (Sodium Cocoyl Glutamate, Glyceryl Caprylate; Citric Acid; Polyglyceryl-6 Oleate; Sodium Surfactin)
6.2.2. Polyols
6.2.2.1. Mannitol
6.2.2.2. Sorbitol
6.2.2.3. Others (Lactitol, Isomalt, xylitol)
6.2.3. Carbohydrates
6.2.3.1. Sucrose
6.2.3.2. Dextrose
6.2.3.3. Starch
6.2.3.4. Others (Lactose, Cellolose, Fructose)
6.2.4. Specialty Excipients
Chapter 7. Market Segmentation 3: By Scale Of Operations Estimates & Trend Analysis
7.1. By Scale of Operation & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operation:
7.2.1. Research
7.2.2. Commercial
Chapter 8. Biopharmaceutical Excipient Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts By Type Of Biologics, 2021-2034
8.1.2. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
8.1.3. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts By Scale of Operation, 2021-2034
8.1.4. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, 2021-2034
8.2.2. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, 2021-2034
8.2.3. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
8.2.4. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, 2021-2034
8.3.2. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, 2021-2034
8.3.3. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
8.3.4. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, (US$ Million) 2021-2034
8.4.2. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.4.3. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
8.4.4. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ABITEC Corporation
9.2.2. Aceto
9.2.3. Angus Chemical
9.2.4. Apothecon
9.2.5. Ashland Global
9.2.6. Associated British Foods plc
9.2.7. Avantor
9.2.8. BASF SE
9.2.9. BioSpectra
9.2.10. BOC Sciences
9.2.11. C.G. Group
9.2.12. Clariant
9.2.13. Colorcon
9.2.14. Croda International Plc
9.2.15. DFE Pharma
9.2.16. DOW
9.2.17. Eastman Chemical
9.2.18. Evonik Industries AG
9.2.19. IMCD N.V.
9.2.20. Innophos
9.2.21. Invitria
9.2.22. J. RETTENMAIER & SÖHNE GmbH + Co KG
9.2.23. Kirsch Pharma
9.2.24. Meggle Pharma
9.2.25. Merck KGaA
9.2.26. Novo Nordisk
9.2.27. Pfanstiehl, Inc.
9.2.28. Pharmonix
9.2.29. Roquette Freres
9.2.30. Shin-Etsu Chemical
9.2.31. Sigachi Industries Limited
9.2.32. Signet Excipients Pvt. Ltd (IMCD)
9.2.33. Spectrum Chemical Manufacturing Corp.
9.2.34. SPI Pharma
9.2.35. Stepan Company
9.2.36. Tereos
9.2.37. The Lubrizol
9.2.38. Wacker Chemie
9.2.39. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們